Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1548 (LINC01548) is a member of the long intergenic non-coding RNAs (lincRNAs), a class of RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and generally lack significant protein-coding potential[3]. LINC01548 is also known as C21orf54 and, according to some databases, as an "Uncharacterized protein encoded by LINC01548." However, there is no current, credible evidence that the locus actually produces a functional protein[3]. Like other lincRNAs, LINC01548 may be involved in the regulation of gene expression through diverse mechanisms, such as acting as a scaffold for chromatin-modifying complexes or modulating transcription in cis or trans, but its specific cellular or disease function has not been definitively characterized[1][3]. There are no known direct drug interactions and it is not a validated therapeutic target. Based on current knowledge, it is best classified as a non-coding RNA with largely unknown biological and pathological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1548 (LINC01548).